Answers are grounded in this paper and cite their sources.
Case report reveals chest pain post-migraine in an individual with coronary vasospasm, suggesting common mechanisms.
Migrainous thoracalgia (MT) refers to chest pain (CP) potentially arising from a neurologic etiology, often temporally linked to migraine. We present a 57-year-old woman with chronic migraine who developed recurrent CP typically following migraine attacks. Despite multiple cardiac evaluations, including cardiac MRI and catheterizations, she was diagnosed with fibromuscular dysplasia, spontaneous coronary artery dissection, and coronary microvascular disease. Her CP partially responded to nitroglycerin and improved modestly with migraine control using ubrogepant and calcium channel blockers. During admission for refractory migraine, she received intravenous lidocaine, magnesium, ketorolac, and neuroleptics, resulting in several months of CP remission despite brief migraine relief. Longitudinal follow-up demonstrated that eptinezumab was associated with improvement in both migraine and CP symptoms. This case highlights the diagnostic challenge of MT and the overlap between migraine and coronary vasospastic or microvascular processes. The observed improvement in CP following migraine-directed therapies raises the possibility of a shared neurovascular mechanism, although causality cannot be established. Greater awareness of MT and interdisciplinary management may improve outcomes in similar patients. Plain Language Summary: This report describes the case of a 57-year-old woman who experienced repeated episodes of chest pain that appeared to be linked to her migraines. Although her heart tests showed some past heart conditions—including a tear in one of her coronary arteries and small blood vessel abnormalities—doctors could not identify an ongoing cardiac cause that fully explained her symptoms. Notably, her chest pain almost always occurred shortly after a migraine attack. Over several years, the patient tried multiple treatments, including migraine medications, heart medications, and nitroglycerin. Some provided temporary relief, but the chest pain continued to recur. In 2022, she was admitted to a headache clinic and received a combination of intravenous treatments for severe migraine. This led to a four-month period without chest pain—the longest relief she had experienced—despite only short-term improvement in her headaches. She was later started on eptinezumab (Vyepti), a medication given every few months to prevent migraines. With this treatment, both her headaches and chest pain became less frequent and less severe. This case highlights a lesser-known condition called “migrainous thoracalgia”, in which chest pain may be related to migraine. While it is not possible to determine cause and effect from a single case, the patient’s improvement with migraine-directed therapies suggests there may be a link between migraine and chest pain in some individuals. Greater awareness of this possible connection may help clinicians better recognize and manage similar cases through collaboration between neurology and cardiology specialists.
No takes yet. Share an insight, caveat, or question.
Zeldich et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: